**5. Drugs used for intraoperative bleeding administration**

Use of synthetic antifibrinolytic agents, such as epsilon-aminocaproic acid (EACA) or tranexamic acid, reduces blood loss and blood transfusion during cardiac procedures and is indicated for blood conservation (Class I, Level A) [15]. The main function of these components is to limit clot formation and ensure adequate blood flow, establishing a dynamic balance with the coagulation system [16].
